Progress in precision medicine and personalised cancer treatment boosts desire for cancer biomarkers. The ability of biomarkers to detect cancer at its earliest stages, information therapeutic solutions, and keep track of the efficiency of cure is boosting its adoption through the Health care industry.Dependant on close consumer, the market is segm